Protective Effect of Keluoxin against Diabetic Nephropathy in Type 2 Diabetic Mellitus Models

Table 2

Comparisons of TC, TG, HDL-C, and LDL-C in different groups after 8 weeks.

Group	N	TC (mmol/L)	TG (mmol/L)	LDL-C (mmol/L)	HDL-C (mmol/L)
Normal	7	1.63 ± 0.09	0.48 ± 0.11	0.48 ± 0.08	0.88 ± 0.07
Model	7	1.45 ± 0.16	0.82 ± 0.29	0.32 ± 0.08	0.83 ± 0.14
Keluoxin	7	1.36 ± 0.26	0.69 ± 0.33	0.29 ± 0.13	0.85 ± 0.17
Irbesartan	7	1.43 ± 0.19	0.71 ± 0.14	0.29 ± 0.16	0.96 ± 0.15

Data were presented as means ± SD. and versus the normal group; and versus the model group.